A5082862247- Advances in Oncology and Radiotherapy
- Lung Cancer Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Radiation Dose and Imaging
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Diversity and Career in Medicine
- Brain Metastases and Treatment
- Endometrial and Cervical Cancer Treatments
- Radiation Therapy and Dosimetry
- Management of metastatic bone disease
- Nutrition and Health in Aging
- Radiology practices and education
- Health and Medical Research Impacts
- Colorectal and Anal Carcinomas
- Economic and Financial Impacts of Cancer
- Advanced Radiotherapy Techniques
- COVID-19 and healthcare impacts
- Head and Neck Surgical Oncology
- Ethics in Clinical Research
- Trauma and Emergency Care Studies
- Multiple and Secondary Primary Cancers
- Global Cancer Incidence and Screening
Icahn School of Medicine at Mount Sinai
2022-2025
New York Proton Center
2025
AstraZeneca (United States)
2023-2025
Columbia University
2018-2021
Georgetown University
2020
Columbia University Irving Medical Center
2017-2020
Chemotherapy, radiotherapy, and surgery constitute the three primary modalities employed in treatment of patients with cancer. Radiotherapy, particular, is a mainstay for cancers breast, esophagus, lung, lymph nodes. Prior studies have shown, however, that radiotherapy can impact heart. Radiation exposure, fact, lead to pathophysiological changes may result short- long-term radiation-induced cardiac toxicities. Such toxicities cause substantial morbidity manifest clinically weeks years after...
"HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)" published on 28 Mar 2025 by National Comprehensive Network.
Glioblastoma, the most common primary brain cancer in adults, is characterized by a poor prognosis and resistance to standard treatments. The advent of immunotherapy has revolutionized treatment several cancers recent years but failed demonstrate benefit patients with glioblastoma. Understanding mechanisms which glioblastoma exerts tumor-mediated immune suppression both tumor microenvironment systemic landscape critical step towards developing effective immunotherapeutic strategies. In this...
The COVID-19 pandemic precipitated drastic changes in cancer care. Its impact on the U.S. head and neck population has yet to be fully understood. This study aims understand of pandemic-related population. An observational patients at a single institution during spring 2020 2019 was performed. Clinical characteristics survival outcomes were analyzed. In 2020, 54 evaluated department radiation oncology vs. 74 seen 2019; 42% female versus 24% (
Whole-brain radiotherapy (WBRT) in patients with brain metastases (BM) is associated neurocognitive decline. Given its crucial role learning and memory, efforts to mitigate this toxicity have mostly focused on sparing radiation the hippocampus. We hypothesized that BM are not evenly distributed across several additional areas may be avoided WBRT based a low risk of developing BM. contoured 2757 lesions large, single-institution database newly diagnosed centroids were mapped onto standard...
Durvalumab is approved for the treatment of adults with unresectable stage III non-small cell lung cancer (NSCLC) post-chemoradiotherapy (CRT). This real-world study describes patient characteristics and durvalumab patterns (number doses therapy duration; initiation delays, interruptions, discontinuations, associated reasons) among VHA-treated patients.This was a retrospective cohort NSCLC receiving at VHA between 1 January 2017 30 June 2020. Patient were presented descriptively.A total 935...
Background: Stereotactic body radiation therapy (SBRT) is a safe and effective treatment option for patients with low to intermediate risk prostate cancer (1). SBRT results in very PSA nadirs secondary the delivery of high biologically doses. Studies reporting on diagnosis, confirmation, management salvageable isolated local failures (ILF) are limited. This study aims determine incidence approach ILF after large single institution cohort. Method: All or localized treated at Georgetown...
Women are underrepresented in academic radiation oncology (RO), particularly leadership positions. In this study, we sought to better understand the characteristics of individuals who currently serve as RO chairpersons at institutions with an associated Accreditation Council for Graduate Medical Education-accredited residency training program. We created a database United States by using publicly available sources, including program websites, hospital/institutional Doximity, LinkedIn,...
PACIFIC established consolidation durvalumab as standard of care for pts with Stage III uNSCLC and no progression after complete cCRT. POSITION aims to identify factors associated failure cCRT during or shortly A retrospective cohort study was conducted using a US-based real-world dataset (Tempus). Eligible had diagnosed from 2010 2021 received without durvalumab. Pts incomplete (Group A), progressed during/within 42 days B) completed C). Descriptive statistics were applied pt...
The aim of this study was to understand the impact COVID-19 pandemic on treatment patterns for patients with stage III unresectable non-small cell lung cancer (uNSCLC). This a retrospective chart review uNSCLC diagnosed between 1 October 2017 and 31 May 2021 in France, Germany, Italy, Spain, Canada, USA. Of 351 enrolled (median age 70 years [range 44-91]; 63.5% male), 88 263 were treated prior (Cohort 1) during 2) pandemic, respectively. majority Cohort (89.8%) 2 (82.5%) received...